» Registration 9:00am - 10:00am

• » [+] Inaugural Sessions

  » [-] Inaugural Sessions

  Session	Speaker	Time
  Inaugural Sessions                                          10:00am - 11:45am
  Welcome Address	Mr.Maulik Jasubhai Group CEO, Chemtech Foundation
  Address by the Chairman	Mr. Ajay Popat Chairman - WaterEX 2013 CAB, CEO-ION Exchange Waterleau Limited
  Keynote Address	Mr. P. D. Samudra Executive Director – Sales & Member of the board, Udhe India & Sr. Vice President – Business Development, Thyssenkrupp Udhe for India & MENA
  Keynote Address	Shri Mahesh Zagade IAS, Commissioner, Food and Drug Administration, Maharashtra
  Guest of Honour	Mr. Suresh Prabhu Chemtech Global Brand Ambassador & Ex Union Minister of Power Chemicals & Fertilizers Environment & Forest
  Concluding Remarks	Mr. Samir Yamdagni President & Managing Director-India, Xylem Water Solutions India Pvt.Ltd

• » [+] Sessions I

  » [-] Sessions I

  Session	Speaker	Time
  Advances in Pharma R&D                                   1:00pm – 2:20pm
  Session Chairman	Dr. Ajit Dangi President & CEO, Danssen Consulting
  Co-Chairman	Dr. Ashok Kumar President - Centre for Research & Development, Ipca Laboratories Ltd.
  Changing paradigm in Pharma R&D	Mr. Babusaheb Patil Chairman, BASP Life Sciences
  Advances in Nanotechnology delivery platforms	Dr. Mangal S. Nagarsenker Professor in Pharmaceutics, Bombay College of Pharmacy
  Q & A

• » [+] Sessions II

  » [-] Sessions II

  Session	Speaker	Time
  Regulatory Compliance - Recent Advance            2:20pm - 3:35pm
  Session Chairman	Mr. Shrikant Ahirro Executive Vice President, Environmental Solutions, Praj Industries Ltd
  Quality by design(QBD)	Mr. Manikandan Project manager, Dr. Reddy’s Laboratories Limited
  Process Analytical Technology(PAT)	Mr. Gopal Nair CEO, Grasp Enterprises
  Q&A


Day II - January 18, 2013



• » [+] Sessions III

  » [-] Sessions III

  Session	Speaker	Time
  Biosimilar Opportunities                                      9:30am - 10:50am
  Session Chairman	Mr. M. S. Shankara Prasad Managing Director, SPC Biotech P. Limited
  Cost by Design CbD for effective development of Biosimilars	Dr. Himanshu Gadgil Vice President, Intas Biopharmaceuticals Ltd.
  Strategic Partnership for entering Biosimilar Market	Mr. Manish Panchal Practice Head – Lifescience, Chemical & Energy, TATA Strategic Management Group
  Q&A
  Tea/Coffee

• » [+] Sessions IV

  » [-] Sessions IV

  Session	Speaker	Time
  Regulatory Land scape                                      11:10am - 12:40pm
  Session Chairman	Mr. Devinder Pal Founder President & CEO, Catalyst Pharma Consulting
  Current Regulatory Position of Biosimilars in India	Ms. Yasmin Shenoy Director, Regulatory Affairs, Sanofi Aventis
  Comparability of Biosimilars – A Global Perspective	Prof. Anurag Rathore Associate Professor, Dept. of Chemical Engineering, IIT Delhi
  Q&A
  Lunch Break

• » [+] Sessions V

  » [-] Sessions V

  Session	Speaker	Time
  Innovation in Biopharmaceuticals          2:00pm – 3:15pm
  Session Chairman	Mr. M. S. Mahadevan President and Chief Executive Officer, Bangalore Biotech Labs Pvt. Ltd.
  Challenges in Successful Production of Biosimilars	Prof. Anurag Rathore Associate Professor, Dept. of Chemical Engineering, IIT Delhi
  Development of Biosimilars in Oncology	Dr.Sunit Maity Associate Divisional Head – Biopharmaceuticals, Avesthagen Limited
  Q&A
  Tea/Coffee Break

• » [+] Sessions VI

  » [-] Sessions VI

  Session	Speaker	Time
  Growth Potential for Biopharmaceuticals           3:35pm - 4:55pm
  Taking biosimilars from lab to clinic: Techno-commercial challenges and future prospects	Dr Arnab Kapat Director, Reliance Institute of Life Sciences
  Therapeutic Potential of Stem Cell Technology	Dr. Pratibha Shetty Principal Scientist, Reliance Life Sciences Pvt. Ltd.
  Q&A

* Confirmation Awaited